• Skip to primary navigation
  • Skip to main content
  • Skip to footer
Exopharm

Exopharm

  • Home
  • Products
  • Partnering
  • Science
  • Resources
    • ASX Announcements
    • Investor Information
    • News & Articles
    • Careers
  • About Us
    • Our Values
    • Our Team
    • Board of Directors
    • Scientific Advisory Board
  • Contact

Our Team

 

Management

Managing Director & Founder

Ian Dixon

Chief Operating Officer

Daisy Scarborough

Chief Technology Officer

Michael West

President - International

David Oxley

Senior Vice President - Finance

Johannes Mühl

Managing Director & Founder

Ian Dixon

PhD, MBA, MAICD

Dr Ian Dixon has a PhD in biomedical engineering from Monash University, an MBA from Swinburne University and professional engineering qualifications.

Ian has been successful in translating technology challenges into valuable businesses and respected intellectual property.

Ian is a co-inventor of Exopharm’s LEAP manufacturing technology and a co-inventor of Fortrexo, part of Exopharm’s EEV pipeline.

Ian brings to Exopharm an extensive technical, commercial and entrepreneurial background.

Before founding Exopharm in 2013, Ian co-founded Cynata Inc, the owner of the Cymerus stem cell technology now being commercialised by ASX-listed clinical-stage Cynata Therapeutics Ltd (ASX:CYP).

He is also non-executive director of NYRADA Inc. (ASX:NYR), co-inventor of Nyrada PCSK9 inhibitor drug NYX-330, and founder and investor of Cardio Therapeutics Pty Ltd.

Ian was previously a founding director of Sydney-based Noxopharm Ltd (ASX:NOX) and non-executive director of Melbourne unlisted company Cell Therapies Pty Ltd.

Chief Operating Officer

Daisy Scarborough

Daisy is an MBA graduate from Melbourne Business School with over 20 years experience leading high performing teams within large organisations.

Daisy embarked her career journey as an Accountant for Angus & Robertson (pre-Kindle days!) before embracing a 10-year career at The Walt Disney Company. Accountant transformed into Change Leader and Special Projects Manager at Disney led to Daisy embedding that Disney magic throughout several mergers and acquisitions across the International markets undertaken by Disney at the time.

Seeking to work for an Australian company and apply her business school knowledge, Daisy spent 7 years at Origin Energy in the highly regulated and competitive Energy Industry leading Customer Operations for the Retail business.

Daisy’s role as Chief of Staff and Head of the Corporate Operations Group at Exopharm is to enable growth, drive performance outcomes and to ensure Exopharm is seen as a leader in exosome medicine. Daisy is responsible for Business Services, Communications, Human Resources, Legal & Intellectual Property.

Chief Technology Officer

Michael West

Mike holds a PhD in Chemistry and graduate qualifications in law and management. He brings 23 years of industry experience in drug development of both pre-clinical and clinical assets. Mike has worked in big-Pharma and has had C-suite roles in several biotechnology companies, bringing a wealth of experience in technology management to Exopharm.

Mike will drive technology and drug development at Exopharm, to reinforce our world leading reputation. Mike is also assisting in the selection of the pipeline products and will contribute to the development programs of those products.

President - International

David Oxley

David Oxley brings extensive commercial experience in life sciences, with a focus in novel technologies in the biotech and life sciences sectors.  He has a proven track record of commercial success, including prosecuting complex, cross-border licensing constructs, inclusive of non-dilutive capital raising, world-wide commercial P&L management, and new product launch experience.

Within the biotech sector, his most recent experience includes service as senior vice president of business development and licensing for Melbourne-based, cellular medicines leader, Mesoblast, where he continues his service as a consultant.

Mr. Oxley’s previous assignments include chief executive officer of a Beijing-based cellular medicines company, and senior vice president of emerging markets and general manager of China for a California-based regenerative medicines company.

Prior to his tenure within the biotech sector, David served a combined eighteen years in executive leadership positions in the life sciences arena, including head of global sales and marketing and head of global government relations for medical devices companies, health-care capital markets management for a leading U.S. bank, healthcare policy advocacy before the U.S. Food and Drug Administration in addition to service as legislative staff for a Member of the United States Congress.

Beyond his corporate management experience, David served on the boards of a privately held antibody-based medical device company in the U.S. and a not-for-profit foundation that is focused on infectious diseases in Africa.

David completed his bachelors’ studies in history at Portland State University and his master’s studies in government and public health at Johns Hopkins University in the U.S.

Senior Vice President - Finance

Johannes Mühl

Johannes is based in Zurich, Switzerland and has a vast network in the life-science industry and is also a successful private investor in the biotech sector.

Johannes has a PhD from Edinburgh Napier University and is a Fellow of the Institute of Public Accountants (FIPA) Australia. Johannes also has a Diploma of International Business Administration from Furtwangen University and is currently studying towards a Master of Public Health at the University of Zurich.

Johannes brings with him a wealth of transferable skills – analytical precision, deep understanding of Finance and Accounting across continents, deal making, and thorough knowledge of the gene therapeutics and diagnostics market.

At Exopharm Johannes is building the profile of Exopharm in the investment community and helping to shape Exopharm’s pipeline products and associated strategy and finance plan.

Previously, Johannes was International Head of Finance and Business Insights at Myriad Genetics where he co-led the organisation through a successful transformation with growth of top and bottom line. He has over 15 years of life-science industry finance experience with roles in Pfizer and Zimmer Biomet.


 

The Team

AllBusiness ServicesCommercialCorporateDownstream ProcessingExperimental BiologyProduct DevelopmentUpstream Processing

Alex Hall

Downstream Processing

Anabel Silva

Product Development

Anna Cifuentes-Rius

Commercial

Caitlin Gladman

VP Communications

Clarissa Whitehead

Experimental Biology

Dana Moussa

Business Services

Dandan Zhu

Downstream Processing

Emma Wanicek

Experimental Biology

Gregor Lichtfuss

Business Services Manager & Co-Founder

Hansi Ranasinghe

Downstream Processing

Hugh Ma

Experimental Biology

Johannes Weber

Upstream Processing

Joseph Lee

Upstream Processing

Kartini Asari

Experimental Biology

Krusha Parmar

Product Development

Ky Vong

Business Services

Mehak Bhola

Commercial

Melanie Schoppet

Product Development

Michael Temopoulos

Business Services

Mozhgan Shojaee

Experimental Biology

Mun Joo Chuei

Product Development

Nenad Sejic

Experimental Biology

Nick Kocovski

Experimental Biology

Niveditha Vathsangam

Upstream Processing

Owen Tatford

Downstream Processing

Sadman Bhuiyan

Downstream Processing

Sam Keenan

Corporate

Sam Law

Downstream Processing

Tahnee Kennedy

Product Development

Thien Dinh

Business Services

Thomas Tsigaras

Business Services

Valeriia Fatykhova

Downstream Processing

Vidhi Patel

Business Services

Yiqin Zhu

CORPORATE

Footer

Resources

  • ASX Announcements
  • Investor Information
  • Board of Directors
  • News & Articles

Information

  • Contact
  • Partnering
  • Join Our Mailing List
  • Privacy, Terms and Conditions
  • Facebook
  • LinkedIn
  • Twitter
  • Vimeo
Copyright © 2022 · Exopharm · ACN 163 765 991 · info@exopharm.com
Level 17/31 Queen St, Melbourne VIC Australia 3000 · P: +61 (0)3 9111 0026 ·

Web Design by Mallee Blue Media
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
Cookie SettingsAccept
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT